Brimonidine Tartrate 0.15%, ophthalmic solution, is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular ...
Please provide your email address to receive an email when new articles are posted on . Data derived from Chauhan MZ, et al. Ophthalmol Glaucoma. 2025;doi:10.1016/j ...
CRANBURY, N.J., April 25, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results